Adolescent HPV Vaccination: A U.S. and Global Perspective on Overcoming Barriers
DOI:
https://doi.org/10.65638/2978-882X.2025.01.10Keywords:
HPV, Human papillomavirus, Vaccination, Immunization disparities, Cancer prevention, Adolescent health, global health equityAbstract
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States and a major contributor to preventable cancers, including cervical, anal, and oropharyngeal cancers, with consequences for individual and population wellbeing. Despite the availability of effective vaccines, HPV vaccination rates remain significantly lower than those for other adolescent immunizations. This health equity-focused editorial explores key factors contributing to low vaccine uptake, including age-based recommendations, testing limitations, affordability, and structural barriers to access. Regional and gender disparities within the U.S., coupled with stark global differences between high-income and low- and middle-income countries, highlight the urgent need for targeted strategies. Improving HPV vaccination coverage requires a multifaceted approach, combining public education, provider advocacy, and capacity building to ensure equitable access. Addressing these gaps is essential to reduce HPV-related disease burden, improve population wellbeing and advance global health equity.
References
Centers for Disease Control and Prevention. (2024, September 24). National Immunization Awareness Month (NIAM). https://www.cdc.gov/vaccines/php/national-immunization-awareness-month/index.html
Kolman, S., & Meyer, C. (2024, February 29). Routine child vaccination rates lower than pre-pandemic levels. National Conference of State Legislatures. https://www.ncsl.org/state-legislatures-news/details/routine-child-vaccination-rates-lower-than-pre-pandemic-levels
Pingali, C., Yankey, D., Elam-Evans, L. D., et al. (2021). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2020. MMWR Morbidity and Mortality Weekly Report, 70(35), 1183-1190. https://doi.org/10.15585/mmwr.mm7035a1
Bruni, L., Diaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F. X., de Sanjosé, S., & Castellsagué, X. (2016). Global estimates of human papillomavirus vaccination coverage by region and income level: A pooled analysis. The Lancet Global Health, 4(7), e453-e463. https://doi.org/10.1016/S2214-109X(16)30099-7
Garcia, M. R., Leslie, S. W., & Wray, A. A. (2025). Sexually transmitted infections. In Stat Pearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK560808/
Mayo Foundation for Medical Education and Research. (2023, December 19). Genital warts. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/genital-warts/symptoms-causes/syc-20355234
Centers for Disease Control and Prevention. (2025, March 3). Cancers caused by HPV. https://www.cdc.gov/hpv/about/cancers-caused-by-hpv.html
World Health Organization. (2020). Global strategy to accelerate the elimination of cervical cancer as a public health problem. https://www.who.int/publications/i/item/9789240014107
Siegel, R.L., Miller, K.D., & Jemal, A. (2020). Cancer Statistics, 2020. American Cancer Society Journals. https://doi.org/10.3322/caac.21590
Shapiro, G. K. (2022). HPV vaccination: an underused strategy for the prevention of cancer. Current Oncology, 29(5), 3780-3792. https://doi.org/10.3390/curroncol29050303
Gong, L., Li, X., & Hou, D. (2025). Stigma and its influencing factors in female patients with high-risk HPV infection: A crosssectional study. Frontiers in Psychiatry, 16, 1613755. https://doi.org/10.3389/fpsyt.2025.1613755
Centers for Disease Control and Prevention. (2025a, February 26). Screening for cervical cancer. https://www.cdc.gov/cervical-cancer/screening/
Peterson, A., Charles, V., Yeung, D., & Coyle, K. (2021). The Health Equity Framework: A Science- and Justice-Based Model for Public Health Researchers and Practitioners. Health promotion practice, 22(6), 741-746. https://doi.org/10.1177/1524839920950730
Acampora, A., Grossi, A., Barbara, A., Colamesta, V., Causio, F. A., Calabrò, G. E., Boccia, S., & de Waure, C. (2020). Increasing HPV vaccination uptake among adolescents: A systematic review. International Journal of Environmental Research and Public Health, 17(21), 7997. https://doi.org/10.3390/ijerph17217997
Underferth, D. (2021, August 18). Should you get a home HPV test? MD Anderson Cancer Center. https://www.mdanderson.org/cancerwise/should-you-get-a-home-hpv-test.h00-159463212.html
Centers for Disease Control and Prevention. (2024, July 9). Clinical overview of HPV. https://www.cdc.gov/hpv/hcp/clinical-overview/
Meites, E., Szilagyi, P. G., Chesson, H. W., Unger, E. R., Romero, J. R., & Markowitz, L. E. (2019). Human papillomavirus vaccination for adults: Updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morbidity and Mortality Weekly Report, 68(32), 698-702.
https://doi.org/10.15585/mmwr.mm6832a3
American Academy of Family Physicians. (2020, February 19). Human papillomavirus vaccine (HPV). https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines/disease-pop-immunization/human-papillomavirus-vaccine-hpv.html
Buskwofie, A., David-West, G., & Clare, C. A. (2020). A review of cervical cancer: incidence and disparities. Journal of the national medical association, 112(2), 229-232. https://doi.org/10.1016/j.jnma.2020.03.002
Fokom Domgue, J., Dille, I., Kapambwe, S., Yu, R., Gnangnon, F., Chinula, L., Murenzi, G., Mbatani, N., Pande, M., Sidibe, F., Kamgno, J., Traore, B., Fazazi, H. E., Diop, M., Tebeu, P. M., Diomande, M. I., Lecuru, F., Adewole, I., Plante, M., Basu, P., … Shete, S. (2024). HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices. Frontiers in public health, 12, 1343064. https://doi.org/10.3389/fpubh.2024.1343064
Nyondo-Mipando, A. L., & Jumbe, V. (2025). Barriers and strategies to enhance HPV vaccine uptake in adolescents living with HIV and their guardians in Lilongwe, Malawi. Scientific reports, 15(1), 32230. https://doi.org/10.1038/s41598-025-03145-x
Centers for Disease Control and Prevention. (2024, July 1). VFC operations guide: July 1, 2024-June 30, 2025. https://beta.cdc.gov/vaccines-for-children/media/pdfs/2024/08/vfc-ops-guide_version-4.0_july-2024_low-res-508-rev-2.pdf
Goldman, N., Nwankwo, C., Charrow, A. P., & Noe, M. H. (2022). State Medicaid coverage of human papillomavirus vaccination in adults and implications for dermatologists. JAMA dermatology, 158(12), 1447-1449.
https://doi.org/10.1001/jamadermatol.2022.3500
Centers for Disease Control and Prevention. (2024b, July 10). How to pay for vaccines. https://www.cdc.gov/vaccines-adults/recommended-vaccines/how-to-pay-adult-vaccines.html
Braveman, P., Egerter, S., & Williams, D. R. (2011). The social determinants of health: coming of age. Annual review of public health, 32(1), 381-398. https://doi.org/10.1146/annurev-publhealth-031210-101218
- Pingali, C., Yankey, D., Elam-Evans, L. D., et al. (2021). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2020. MMWR Morbidity and Mortality Weekly Report, 70(35), 1183-1190. https://doi.org/10.15585/mmwr.mm7035a1
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. https://doi.org/10.1037/e601292007-001
Dunne, E. F., Markowitz, L. E., Chesson, H., Curtis, C. R., Saraiya, M., Gee, J., & Unger, E. R. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm
McLendon, L., Puckett, J., Green, C., James, J., Head, K. J., Lee, H. Y., Young-Pierce, J., Beasley, M., & Daniel, C. L. (2021). Factors associated with HPV vaccination initiation among United States college students. Human Vaccines & Immunotherapeutics, 17(4), 1033-1043. https://doi.org/10.1080/21645515.2020.1847583
Walker, T. Y., Elam-Evans, L. D., Singleton, J. A., Yankey, D., Markowitz, L. E., Fredua, B., Williams, C. L., Meyer, S. A., & Stokley, S. (2017). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2016. MMWR Morbidity and Mortality Weekly Report, 66(33), 874-882. https://doi.org/10.15585/mmwr.mm6633a2
Cancer Trends Progress Report. (2025, April). National Cancer Institute, NIH, DHHS. https://progressreport.cancer.gov
World Health Organization. (2024, March 5). Human papillomavirus and cancer. https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer
Bruni, L., Saura-Lázaro, A., Montoliu, A., Brotons, M., Alemany, L., Diallo, M. S., Afsar, O. Z., LaMontagne, D. S., Mosina, L., Contreras, M., Velandia-González, M., Pastore, R., Gacic-Dobo, M., & Bloem, P. (2021). HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019. Preventive Medicine, 144, 106399. https://doi.org/10.1016/j.ypmed.2020.106399
Ebrahimi, N., Yousefi, Z., Khosravi, G., Malayeri, F. E., Golabi, M., Askarzadeh, M., Shams, M. H., Ghezelbash, B., & Eskandari, N. (2023). Human papillomavirus vaccination in low- and middle-income countries: Progression, barriers, and future prospective. Frontiers in Immunology, 14, 1150238. https://doi.org/10.3389/fimmu.2023.1150238
Binagwaho, A., Wagner, C. M., Gatera, M., Karema, C., Nutt, C. T., & Ngabo, F. (2012). Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bulletin of the World Health Organization, 90(8), 623-628. https://doi.org/10.2471/BLT.11.097253
Ward, K., Quinn, H., Menzies, R., & McIntyre, P. (2013). A history of adolescent school based vaccination in Australia. Communicable diseases intelligence quarterly report, 37(2), E168-E174. https://doi.org/10.33321/cdi.2013.37.23
Babu, M., Thakur, A., Sravyasri, M., Gunjan, G., Shetty, S., Das, K., Pandya, I. Y., & Lavanya (2024). Empowering Women's Health: Examining the Impact of Human Papillomavirus (HPV) Vaccination on Cervical Cancer Treatment and Beyond. Cureus, 16(8), e67287. https://doi.org/10.7759/cureus.67287
United Nations Development Programme. Goal 3: Good health and well-being. https://www.undp.org/sustainable-development-goals/good-health
Boccalini S. (2025). Value of Vaccinations: A Fundamental Public Health Priority to Be Fully Evaluated. Vaccines, 13(5), 479. https://doi.org/10.3390/vaccines13050479
Waheed, D., et al. (2022, October). Challenges with HPV vaccine confidence in low- and middle-income countries. HPV World, 214
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Valeria Gutierrez Garcia, Rachel Mpanumpanu, Asha Ciara Sneed, Natalie Romero, Lunthita M. Duthely (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
